Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001715 · ClinicalTrials.gov registry record
Evaluation of Patients With Blood Disorders
A clinical trial of Hematologic Disease, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 898
- Enrollment target
- 1
- Study location
NCT00001715 is a study of Hematologic Disease that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 898 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00001715, a study of Hematologic Disease, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 898 participants
- Enrollment target
- 1
- Study location
Study Summary
The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians.This study was developed to evaluate and possibly treat patients with blood disorders. The Hematology Service of the National Institutes of Health is responsible for the care of patients participating in research studies. In addition the Hematology Service also provides consultation for small groups of patients with blood disorders that have not been diagnosed or that may need special testing. This study will also provide doctors at the NIH the opportunity to learn more about a wide range of blood disorders and conditions. Patients participating in this study will be evaluated over the course of several outpatient visits and will continue to be cared for by their regular physician.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 898 participants |
| Start Date | 1998-04-21 |
| Est. Completion | 2017-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001715
The ClinicalTrials.gov registry entry for NCT00001715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 898 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematologic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00001715 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001715 about?
NCT00001715 is a clinical study titled "Evaluation of Patients With Blood Disorders". The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and ...
What is the current status of trial NCT00001715?
This trial is currently completed. The enrollment target is 898 participants. The study started on 1998-04-21. Estimated completion is 2017-08-23.
What conditions does trial NCT00001715 study?
This clinical trial studies the following conditions: Hematologic Disease.
Who is sponsoring clinical trial NCT00001715?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001715 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.